Based on data from IMS, the leading pharmacy sales measurement company, Alimentary Health is delighted to announce that Alflorex® achieved its target milestone of brand leadership by value in its market segment in Ireland in 20151.
“Given the success of the 35624™ strain in the US, where it has been the No.1 gastroenterologist recommended strain for the last 5 years running2, it is not a surprise thatAlflorex® has become the leading brand in Ireland,” commented AH Chief Financial Officer & Managing Director, Brian Barrett. “The combination of a strong recommendation from Health Care Professionals and a positive consumer experience is driving sales in Ireland and this is a model that we hope to replicate in other European countries moving forward,” he said.
As well as Gastroenterologists, Alflorex® has been particularly warmly welcomed by dieticians in Ireland who are often at the front-line for the management of patients.
“Dieticians tell us repeatedly that there is nothing like Alflorex® available to them, and they find it can often avoid the need for a more extreme exclusion regime.” Comments Technical Director Eileen Murphy.
Commenting on the brand’s 2015 performance Barry Kiely CEO adds:
“Whilst we can look back at a successful achievement last year, the 2016 – 2017 period should see further growth from continued brand penetration, as well as the first launches from a suite of exciting new products…”
References:1. IMS Data. January 2016, 2. Among gastroenterologists and doctors who recommended a brand of probiotic in a Symphony Health Solutions 2014 survey.